Eicosanoids and renal damage in cardiometabolic syndrome

Expert Opinion on Drug Metabolism and Toxicology

Volumn 4, Issue 2, 2008, Pages 165-174

  Imig, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cytokines; Epoxide hydrolase; Epoxyeicosatrienoic acids; Inflammation; Kidney; Obesity

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ADIPOCYTOKINE; ADIPONECTIN; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR ANTAGONIST; CYCLOOXYGENASE 2 INHIBITOR; EPOXIDE; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE INHIBITOR; ETANERCEPT; GELATINASE A; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NORDIHYDROGUAIARETIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; RESISTIN; ROFECOXIB; TELMISARTAN; THROMBOXANE A2; THROMBOXANE RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOMETABOLIC SYNDROME X; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; DRUG METABOLISM; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN FUNCTION; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DRUG DELIVERY SYSTEMS; EICOSANOIDS; ENZYME INHIBITORS; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; HUMANS; KIDNEY FAILURE, CHRONIC; METABOLIC SYNDROME X;

EID: 39749161642     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.4.2.165     Document Type: Review

References (108)